Gene Expression Changes in Small Cell Lung Cancer Due to EGFR Mutation
Author Information
Author(s): Pedersen M W, Thykjær T, Ørntoft T F, Damstrup L, Poulsen H S
Primary Institution: Department of Radiation Biology, The Finsen Centre, National University Hospital, Section 6321, Copenhagen, DK-2100, Denmark
Hypothesis
How does the EGFRvIII mutation contribute to the malignant phenotype in small-cell lung cancer?
Conclusion
The study found that the EGFRvIII mutation alters the expression of genes that control cell growth, survival, and motility in small-cell lung cancer.
Supporting Evidence
- Previous studies have shown a correlation between EGFRvIII expression and a more malignant phenotype in various cancers.
- The study used the GeneChip Hu6800Set to identify gene expression changes.
- Selected results were verified using Northern hybridisations and Western blot analyses.
Takeaway
Scientists studied a type of lung cancer and found that a specific mutation changes how certain genes work, which can make the cancer more aggressive.
Methodology
The study used a transfected small-cell lung cancer cell line and analyzed gene expression changes using GeneChip technology.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website